Purpose To evaluate the efficacy and safety of adalimumab (ADA, Humira®) for treatment of
non-infectious uveitis (NIU) refractory to conventional medications. Methods Anti-tumor …

The study aim was to evaluate the efficacy of adalimumab (ADA) in a large series of Behçet's
disease (BD)-related uveitis. We performed a multicenter retrospective observational study …

Objective. Behçet's disease (BD) is a chronic multisystem inflammatory disorder associated
to uveitis that may represent a serious sight-threatening condition. The purpose of the …

Purpose To examine the long-term efficacy and safety of adalimumab (ADA) in patients with
Behçet uveitis (BU). Methods A systematic review and meta-analysis of observational …

Background To compare the efficacy of Adalimumab (ADA) in noninfectious anterior uveitis
(AU) and posterior segment (PS) involvement, associated with different conditions, with a …

Objective. To assess the efficacy of other biologic therapies, different from IFX and ADA, in
patients with Behçet's disease uveitis (BU). Methods. Multicentre study of 124 patients with …

Introduction To evaluate the efficacy of SB5, an adalimumab biosimilar, in the management
of Behçet's syndrome (BS)-related uveitis. Methods Data from eight BS patients (16 eyes) …

Purpose To report the clinical outcomes of adalimumab in treating refractory Behcet's
disease (BD)-related uveitis in paediatric or adolescent patients. Methods Retrospective …

Purpose To assess efficacy, safety, and cost-effectiveness of adalimumab (ADA) therapy
optimization in a large series of patients with uveitis due to Behçet disease (BD) who …

PURPOSE: To assess the safety and to conduct a preliminary assessment of efficacy of
intravitreal infliximab, an anti–tumor necrosis factor antibody, for sight-threatening relapsing …